Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease-1: Study Protocol for a Multicenter Clinical Trial.

Weir MA, Walsh M, Cuerden MS, Sontrop JM, Chambers LC, Garg AX.

Can J Kidney Health Dis. 2018 Dec 5;5:2054358118813088. doi: 10.1177/2054358118813088. eCollection 2018.

2.

Myocardial remodeling after kidney transplantation: a case report.

Lukaszewski M, Kosiorowska K, Kaminska D, Obremska M, Mazanowska O, Krajewska M.

BMC Nephrol. 2018 Dec 20;19(1):372. doi: 10.1186/s12882-018-1185-x.

3.

Syndrome of uremic encephalopathy and bilateral basal ganglia lesions in non-diabetic hemodialysis patient: a case report.

Gong WY, Li SS, Yu ZC, Wu HW, Yin LH, Mei LF, Liu FN.

BMC Nephrol. 2018 Dec 19;19(1):370. doi: 10.1186/s12882-018-1174-0.

4.

Chronic kidney disease following twin-to-twin transfusion syndrome-long-term outcomes.

Melhem NZ, Ledermann S, Rees L.

Pediatr Nephrol. 2018 Dec 17. doi: 10.1007/s00467-018-4176-z. [Epub ahead of print]

PMID:
30560449
5.

Type B lactic acidosis from fluorouracil in fluorouracil, oxaliplatin and leucovorin treatment for carcinoma of the colon in a hemodialysis patient.

Yeung EK, Copland MA, Gill S.

Clin Kidney J. 2018 Dec;11(6):786-787. doi: 10.1093/ckj/sfy012. Epub 2018 Mar 12.

6.

Treatment of multiple myeloma with renal involvement: the nephrologist's view.

Favà A, Fulladosa X, Montero N, Draibe J, Torras J, Gomà M, Cruzado JM.

Clin Kidney J. 2018 Dec;11(6):777-785. doi: 10.1093/ckj/sfy065. Epub 2018 Aug 1.

7.

A randomized, phase 2 study of ASP0113, a DNA-based vaccine, for the prevention of CMV in CMV-seronegative kidney transplant recipients receiving a kidney from a CMV-seropositive donor.

Vincenti F, Budde K, Merville P, Shihab F, Ram Peddi V, Shah M, Wyburn K, Cassuto-Viguier E, Weidemann A, Lee M, Flegel T, Erdman J, Wang X, Lademacher C.

Am J Transplant. 2018 Dec;18(12):2945-2954. doi: 10.1111/ajt.14925. Epub 2018 Jun 20.

PMID:
29745007

Supplemental Content

Loading ...
Support Center